Related Experiment Videos
Evidence for compromised aldosterone synthase enzyme activity in preeclampsia
Kushiar Shojaati1, Maja Causevic, Bert Kadereit
1Division of Nephrology/Hypertension, University of Berne, Berne, Switzerland.
Kidney International
|December 1, 2004
Summary
Aldosterone deficiency in preeclampsia is linked to compromised CYP11B2 enzyme activity, potentially caused by the V386A mutation. This may increase the risk of placental issues and preeclampsia development.
Area of Science:
- Endocrinology
- Reproductive Biology
- Genetics
Background:
- Normal pregnancy involves increased aldosterone (Aldo) and volume expansion.
- Preeclampsia is characterized by low Aldo levels and intravascular volume depletion.
- The molecular basis of compromised Aldo synthesis in preeclampsia requires characterization.
Purpose of the Study:
- To characterize compromised aldosterone synthesis in preeclampsia.
- To identify the molecular basis of this compromised synthesis.
- To investigate the role of CYP11B2 mutations in preeclampsia.
Main Methods:
- Recruited 66 pregnant women (24 normal, 42 preeclamptic).
- Measured steroid hormone excretion via gas chromatography-mass spectrometry to assess CYP11B2 and CYP11B1 activity.
- Screened for CYP11B2 mutations using PCR-based methods (SSCP, restriction analysis, sequencing).
Main Results:
- Preeclamptic women showed significantly reduced CYP11B2 activity (3.9-fold decrease in TH-Aldo excretion).
- Ratios indicated diminished methyl oxidase (MO) activity in preeclampsia.
- The CYP11B2 mutation V386A, previously linked to impaired MO activity, was exclusively found in preeclamptic women (17%).
Conclusions:
- Aldosterone deficiency, due to compromised MO activity in synthesis, contributes to volume depletion and may increase preeclampsia risk.
- The V386A mutation in CYP11B2 may identify a subgroup of preeclamptic mothers at higher risk.
- This finding highlights a potential genetic predisposition to preeclampsia linked to steroid hormone synthesis defects.